Activation of adenosine A3 receptors reduces ischemic brain injury in rodents - PubMed (original) (raw)
. 2006 Dec;84(8):1848-55.
doi: 10.1002/jnr.21071.
Affiliations
- PMID: 17016854
- DOI: 10.1002/jnr.21071
Activation of adenosine A3 receptors reduces ischemic brain injury in rodents
Guann-Juh Chen et al. J Neurosci Res. 2006 Dec.
Abstract
Adenosine A3 receptor (A3R) agonists have been shown to reduce cardiac and lung injury, but the protective roles of A3R agonists in the CNS are not well characterized. The protective effect of selective A3R agonist chloro-N(6)-(3-iodo-benzyl)-adenosine-5'-N-methyluronamide (Cl-IB-MECA) was first examined in primary cortical cultures. In cortical culture, Cl-IB-MECA pretreatment antagonized the hypoxia-mediated decrease in cell viability. In vivo, Cl-IB-MECA or vehicle was given intracerebroventricularly or intravenously to anesthetized rats. Animals were subjected to focal cerebral ischemia induced by transient middle cerebral artery (MCA) ligation. Intracerebroventricular or repeated intravenous administration (i.e., at 165 min and 15 min before MCA ligation) of Cl-IB-MECA did not alter blood pressure during ischemia but increased locomotor activity and decreased cerebral infarction 2 days after. In these animals, Cl-IB-MECA also reduced the density of TUNEL labeling in the lesioned cortex. The possibility of endogeneous neuroprotection was further examined in A3R knockout mice. After MCA ligation, an increase in cerebral infarction was found in the A3R knockouts compared with the A3R wild-type controls, suggesting that A3Rs are tonically activated during ischemia. Additionally, intracerebroventricular pretreatment with Cl-IB-MECA decreased the size of infarction in the wild-type controls, but not in the A3R knockout animals, suggesting that Cl-IB-MECA-induced protection was mediated through the A3 receptors. Collectively, these data suggest that Cl-IB-MECA reduced cerebral infarction through the activation of A3Rs and suppression of apoptosis.
Similar articles
- Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
Galvao J, Elvas F, Martins T, Cordeiro MF, Ambrósio AF, Santiago AR. Galvao J, et al. Exp Eye Res. 2015 Nov;140:65-74. doi: 10.1016/j.exer.2015.08.009. Epub 2015 Aug 18. Exp Eye Res. 2015. PMID: 26297614 - Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.
Mulloy DP, Sharma AK, Fernandez LG, Zhao Y, Lau CL, Kron IL, Laubach VE. Mulloy DP, et al. Ann Thorac Surg. 2013 May;95(5):1762-7. doi: 10.1016/j.athoracsur.2013.01.059. Epub 2013 Mar 28. Ann Thorac Surg. 2013. PMID: 23541429 Free PMC article. - Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, Auchampach JA. Ge ZD, et al. J Pharmacol Exp Ther. 2006 Dec;319(3):1200-10. doi: 10.1124/jpet.106.111351. Epub 2006 Sep 19. J Pharmacol Exp Ther. 2006. PMID: 16985166 - Adenosine receptors as potential targets in melanoma.
Montinaro A, Iannone R, Pinto A, Morello S. Montinaro A, et al. Pharmacol Res. 2013 Oct;76:34-40. doi: 10.1016/j.phrs.2013.07.002. Epub 2013 Jul 13. Pharmacol Res. 2013. PMID: 23856527 Review. - A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.
Jacobson KA, Merighi S, Varani K, Borea PA, Baraldi S, Aghazadeh Tabrizi M, Romagnoli R, Baraldi PG, Ciancetta A, Tosh DK, Gao ZG, Gessi S. Jacobson KA, et al. Med Res Rev. 2018 Jul;38(4):1031-1072. doi: 10.1002/med.21456. Epub 2017 Jul 6. Med Res Rev. 2018. PMID: 28682469 Free PMC article. Review.
Cited by
- Search for adenosine A2A spare receptors on peripheral human lymphocytes.
Jacquin L, Franceschi F, By Y, Durand-Gorde JM, Condo J, Deharo JC, Michelet P, Fenouillet E, Guieu R, Ruf J. Jacquin L, et al. FEBS Open Bio. 2012 Nov 17;3:1-5. doi: 10.1016/j.fob.2012.11.004. Print 2013. FEBS Open Bio. 2012. PMID: 23847753 Free PMC article. - The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice.
Fishman P, Cohen S, Itzhak I, Amer J, Salhab A, Barer F, Safadi R. Fishman P, et al. Int J Mol Med. 2019 Dec;44(6):2256-2264. doi: 10.3892/ijmm.2019.4364. Epub 2019 Oct 3. Int J Mol Med. 2019. PMID: 31638172 Free PMC article. - Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor.
Auchampach JA, Gizewski ET, Wan TC, de Castro S, Brown GG Jr, Jacobson KA. Auchampach JA, et al. Biochem Pharmacol. 2010 Apr 1;79(7):967-73. doi: 10.1016/j.bcp.2009.11.009. Epub 2009 Nov 14. Biochem Pharmacol. 2010. PMID: 19917269 Free PMC article. - Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
Rivera-Oliver M, Díaz-Ríos M. Rivera-Oliver M, et al. Life Sci. 2014 Apr 17;101(1-2):1-9. doi: 10.1016/j.lfs.2014.01.083. Epub 2014 Feb 13. Life Sci. 2014. PMID: 24530739 Free PMC article. Review. - Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury.
Bozdemir E, Vigil FA, Chun SH, Espinoza L, Bugay V, Khoury SM, Holstein DM, Stoja A, Lozano D, Tunca C, Sprague SM, Cavazos JE, Brenner R, Liston TE, Shapiro MS, Lechleiter JD. Bozdemir E, et al. Neurotherapeutics. 2021 Oct;18(4):2707-2721. doi: 10.1007/s13311-021-01113-7. Epub 2021 Oct 4. Neurotherapeutics. 2021. PMID: 34608616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources